Gilgamesh Pharmaceuticals is developing a diverse ... with composition of matter intellectual property (IP) coverage. GM-1020 is a small-molecule orally active antagonist of the N-methyl-d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback